Pay in 4 interest-free payments of $5.05 Learn more
Ships within 48 hours · Estimated delivery Sep 8 - Sep 13
The present study proposes a novel combination therapy for breast cancer that involves the utilization of EGCG-enabled phosphatase and acidic dual-responsive nanotherapeutic agents, which demonstrate the capacity to penetrate deep tumor tissue
doi: 10.1016/j.cca.2019.07.032 165 SantiagoARBoiaRAiresIDAmbrsioAFFernandesR
Cordoba, F
Thats why we take a holistic view, integrating glutathione with other treatments, habits, and strategies that support your whole-body health
Conventional drug carriers such as PLGA and PEG provide controlled release and stability but lack inherent bioactivity and may pose cytotoxic risks (Stewart et al
US$ 29.80
US$ 28.94
US$ 20.96
US$ 29.85
US$ 28.72
US$ 25.86
